DMK PHARMACEUTICALS CORPORATION Income (Loss) from Continuing Operations, Per Basic Share
DMK PHARMACEUTICALS CORPORATION reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.25 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for the quarter ending 2023-09-30 was -$0.25.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for the quarter ending 2023-06-30 was -$2.79.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for the quarter ending 2023-03-31 was -$0.06.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for the quarter ending 2022-09-30 was -$1.99.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.17.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for fiscal 2021 was -$0.24.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for fiscal 2014 was -$1.11.
- DMK PHARMACEUTICALS CORPORATION income (loss) from continuing operations, per basic share for fiscal 2013 was -$1.21.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$0.25 10-Q · filed 2023-11-14 | -$4.53 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | -$2.79 10-Q · filed 2023-08-21 | -$6.81 10-Q · filed 2023-08-21 | |||||
| 2023-03-31 | -$0.06 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$0.17 10-K · filed 2023-03-16 | ||||||
| 2022-09-30 | -$1.99 10-Q · filed 2023-11-14 | -$0.03 10-Q · filed 2022-11-14 | -$10.65 10-Q · filed 2023-11-14 | -$0.15 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | -$3.89 10-Q · filed 2023-08-21 | -$0.06 10-Q · filed 2022-08-10 | -$8.66 10-Q · filed 2023-08-21 | -$0.13 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | -$0.07 10-Q · filed 2023-05-15 | ||||||
| 2021-12-31 | -$0.24 10-K · filed 2023-03-16 | ||||||
| 2021-09-30 | -$0.03 10-Q · filed 2022-11-14 | -$0.19 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.05 10-Q · filed 2022-08-10 | -$0.16 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | -$0.11 10-Q · filed 2022-05-16 | ||||||
| 2014-03-31 | -$1.11 10-K · filed 2014-06-23 | ||||||
| 2013-03-31 | -$1.21 10-K · filed 2014-06-23 |